Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: Preliminary results of a phase II trial

Seminars in Oncology

Volumn 27, Issue 1 SUPPL. 1, 2000, Pages 20-24

  Colomer, R ^a   Llombart, A ^a   Lluch, A ^a   Ojeda, B ^a   Barnadas, A ^a   Caranana, V ^a   Fernandez, Y ^a   De Paz, L ^a   Guillem, V ^a   Alonso, S ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CIMETIDINE; DEXAMETHASONE; DEXCHLORPHENIRAMINE; DIPHENHYDRAMINE; GEMCITABINE; PACLITAXEL; RANITIDINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FEVER; HUMAN; LEUKOPENIA; MULTICENTER STUDY; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; DRUG ADMINISTRATION SCHEDULE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; REMISSION INDUCTION;

EID: 0033956168     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)